BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17620307)

  • 21. Tumor phenotype and susceptibility to progression as an expression of subpopulations of initiated murine cells.
    Becker FF
    Cancer Res; 1985 Feb; 45(2):768-73. PubMed ID: 2578306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-linked dominant growth suppression of transplanted tumors in C57BL/6J-scid mice.
    Wood M; Udagawa T; Hida Y; D'Amato RJ
    Cancer Res; 2005 Jul; 65(13):5690-5. PubMed ID: 15994943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
    Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C57BR/cdJ hepatocarcinogen susceptibility genes act cell-autonomously in C57BR/cdJ<-->C57BL/6J chimeras.
    Chiaverotti TA; Drinkwater NR
    Cancer Res; 2003 Aug; 63(16):4914-9. PubMed ID: 12941815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse.
    Yang W; Bancroft L; Liang J; Zhuang M; Augenlicht LH
    Cancer Res; 2005 Oct; 65(20):9363-8. PubMed ID: 16230399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duality of p27Kip1 function in tumorigenesis.
    Sicinski P; Zacharek S; Kim C
    Genes Dev; 2007 Jul; 21(14):1703-6. PubMed ID: 17639075
    [No Abstract]   [Full Text] [Related]  

  • 28. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.
    Urbanik T; Boger RJ; Longerich T; Becker K; Ehrenberg KR; Hövelmeyer N; Hahn M; Schuchmann M; Jäger D; Waisman A; Wörns MA; Schulze-Bergkamen H
    J Hepatol; 2012 Nov; 57(5):995-1003. PubMed ID: 22728872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p27Kip1 inactivation provides a proliferative advantage to transplanted hepatocytes in DPPIV/Rag2 double knockout mice after repeated host liver injury.
    Yuan RH; Ogawa A; Ogawa E; Neufeld D; Zhu L; Shafritz DA
    Cell Transplant; 2003; 12(8):907-19. PubMed ID: 14763511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency in the gap junction protein connexin32 alters p27Kip1 tumor suppression and MAPK activation in a tissue-specific manner.
    King TJ; Gurley KE; Prunty J; Shin JL; Kemp CJ; Lampe PD
    Oncogene; 2005 Mar; 24(10):1718-26. PubMed ID: 15608667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual role for Id2 in chemical carcinogen-induced skin tumorigenesis.
    Tokuriki A; Iyoda T; Inaba K; Ikuta K; Fujimoto S; Kumakiri M; Yokota Y
    Carcinogenesis; 2009 Sep; 30(9):1645-50. PubMed ID: 19587095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term culture-initiating cells of murine bone marrow cells in vitro.
    Wang YY; Yang Y; Chen Q; Yu J; Hou Y; Han L; He J; Jiao D; Yu H
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):711-20. PubMed ID: 18685787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype.
    Besson A; Hwang HC; Cicero S; Donovan SL; Gurian-West M; Johnson D; Clurman BE; Dyer MA; Roberts JM
    Genes Dev; 2007 Jul; 21(14):1731-46. PubMed ID: 17626791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of cirrhosis on the development of experimental hepatic metastases by B16F1 melanoma cells in C57BL/6 mice.
    Qi K; Qiu H; Sun D; Minuk GY; Lizardo M; Rutherford J; Orr FW
    Hepatology; 2004 Nov; 40(5):1144-50. PubMed ID: 15382152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
    Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
    J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.